Human pancreatic ribonuclease (RNase 1) is an enzyme that can block the flow of biochemical information by catalyzing the cleavage of cellular RNA. Our intent is to use ideas and methods from enzymology, biochemistry and molecular biology, and cell biology to reveal attributes of the structure and function of RNase 1 that can lead to toxic activity against cancer cells, and to enhance that activity. During the next grant period, this intent will be achieved in four Specific Aims.
Specific Aims. In Aim 1, we shall identify specific glycans on the surface of human cells that interact with RNase 1, characterize those interactions, and assess their biological relevance.
In Aim 2, we shall develop small-molecule fluorogenic probes for two critical steps in RNase 1-mediated cytotoxicity: endocytosis and endosomal escape.
In Aim 3, we shall determine the fate of cellular RNA exposed to an RI-evasive variant of RNase 1, and whether the products of catalysis by RNase 1 are substrates for a cytosolic enzyme, RtcB.
In Aim 4, we shall produce RNase 1 with human-like glycosylation and determine the effect of the glycans on the biochemical and biological attributes of the enzyme. Significance. The results of the research proposed herein will provide a detailed biochemical understanding of the antitumoral activity of RNase 1, and could ultimately lead to new chemotherapeutic agents based on variants of an endogenous human enzyme.
This research project is focused on the development of a new class of chemotherapeutic agents for the treatment of cancer. The agents are based on ribonuclease, which is a human enzyme that can enter human cells and catalyze the cleavage of RNA, leading to cell death. The goal of the project is to obtain fundamental insights into the relationship between the amino-acid sequence of ribonuclease, its three-dimensional structure, and its biological function, and to use those insights to create novel ribonucleases of potential therapeutic utility.
|Tonelli, Marco; Eller, Chelcie H; Singarapu, Kiran K et al. (2015) Assignments of RNase A by ADAPT-NMR and enhancer. Biomol NMR Assign 9:81-8|
|D'Avino, Chiara; Paciello, Rolando; Riccio, Gennaro et al. (2014) Effects of a second-generation human anti-ErbB2 ImmunoRNase on trastuzumab-resistant tumors and cardiac cells. Protein Eng Des Sel 27:83-8|
|Lavis, Luke D; Raines, Ronald T (2014) Bright building blocks for chemical biology. ACS Chem Biol 9:855-66|
|Eller, Chelcie H; Yang, Guangbin; Ouerfelli, Ouathek et al. (2014) Affinity of monoclonal antibodies for Globo-series glycans. Carbohydr Res 397:1-6|
|Desai, Kevin K; Cheng, Chin L; Bingman, Craig A et al. (2014) A tRNA splicing operon: Archease endows RtcB with dual GTP/ATP cofactor specificity and accelerates RNA ligation. Nucleic Acids Res 42:3931-42|
|Desai, Kevin K; Bingman, Craig A; Cheng, Chin L et al. (2014) Structure of RNA 3'-phosphate cyclase bound to substrate RNA. RNA 20:1560-6|
|Eller, Chelcie H; Lomax, Jo E; Raines, Ronald T (2014) Bovine brain ribonuclease is the functional homolog of human ribonuclease 1. J Biol Chem 289:25996-6006|
|Zasadil, Lauren M; Andersen, Kristen A; Yeum, Dabin et al. (2014) Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles. Sci Transl Med 6:229ra43|
|Lomax, Jo E; Bianchetti, Christopher M; Chang, Aram et al. (2014) Functional evolution of ribonuclease inhibitor: insights from birds and reptiles. J Mol Biol 426:3041-56|
|Sundlass, Nadia K; Eller, Chelcie H; Cui, Qiang et al. (2013) Contribution of electrostatics to the binding of pancreatic-type ribonucleases to membranes. Biochemistry 52:6304-12|
Showing the most recent 10 out of 81 publications